The Technical Analyst
Medifast Inc [MED]
Exchange: NYSE Sector: Consumer Cyclical Industry: Personal Services
Medifast Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
2.64% $25.62
America/New_York / 9 mai 2024 @ 11:51
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 280.21 mill |
| EPS: | 6.19 |
| P/E: | 4.14 |
| Earnings Date: | Aug 05, 2024 |
| SharesOutstanding: | 10.94 mill |
| Avg Daily Volume: | 0.461 mill |
| RATING 2024-05-08 |
|---|
| A |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Sell | |
| P/E: | Neutral | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.24x |
| Company: PE 4.14 | sector: PE 17.52 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.28x |
| Company: PE 4.14 | industry: PE 14.56 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 24.05 - 27.17 ( +/- 6.10%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-03-15 | Maloney James P. | Sell | 73 | Common Stock |
| 2024-03-15 | Maloney James P. | Sell | 119 | Common Stock |
| 2024-03-15 | Maloney James P. | Sell | 424 | Common Stock |
| 2024-03-15 | Mackenzie Jonathan Barrett | Sell | 51 | Common Stock |
| 2024-03-15 | Mackenzie Jonathan Barrett | Sell | 83 | Common Stock |
| INSIDER POWER |
|---|
| 34.18 |
| Last 99 transactions |
| Buy: 170 665 | Sell: 85 180 |
Forecast:
13:32 - $25.53
Live Trading Signals (every 1 min)
Forecast
1: 12:02 - $25.63
Forecast 2: 12:52 - $25.56
Forecast 3: 13:32 - $25.53
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $25.62 (2.64% ) |
| Volume | 0.0912 mill |
| Avg. Vol. | 0.461 mill |
| % of Avg. Vol | 19.78 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For MED
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
MED
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.
Latest Press Releases
2024-05-06 03:30:00 - Press Release
Investigation Alert: The Schall Law Firm Announces It Is Investigating Claims Against Medifast, Inc. And Encourages Investors To Contact The Firm
Los angeles, ca / accesswire / may 6, 2024 / the schall law firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of medifast, inc. ("medifast" or "the company") (nyse:med) for violations of the securities laws. the investigation focuses on whether the company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
2024-04-30 18:40:00 - Press Release
Important Investor Alert: The Schall Law Firm Announces It Is Investigating Claims Against Medifast, Inc. And Encourages Investors To Contact The Firm
Los angeles, ca / accesswire / april 30, 2024 / the schall law firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of medifast, inc. ("medifast" or "the company") (nyse:med) for violations of the securities laws. the investigation focuses on whether the company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
2024-04-29 16:05:00 - Press Release
Medifast Announces First Quarter 2024 Financial Results
Baltimore--(business wire)--medifast (nyse: med), the health and wellness company known for its habit-based and coach-guided lifestyle solution, optavia®, today reported results for the first quarter ended march 31, 2024. first quarter 2024 revenue of $174.7 million, with revenue per active earning coach of $4,623 independent active earning optavia coaches of 37,800 net income of $8.3 million (non-gaap adjusted net income of $7.2 million) earnings per diluted share ("eps") of $0.76 (non-gaap ad.
2024-04-15 16:05:00 - Press Release
Medifast To Announce Financial Results For The First Quarter Ended March 31, 2024
Baltimore--(business wire)--medifast (nyse: med), the health and wellness company known for its habit-based and coach-guided lifestyle solution, optavia®, will announce financial results for the first quarter ended march 31, 2024 on monday, april 29, 2024, after market close. the company will host a conference call to discuss the results with additional comments and details. company participants will be dan chard, chairman and chief executive officer, and jim maloney, chief financial officer. t.
2024-02-06 16:05:00 - Press Release
Medifast To Announce Financial Results For The Fourth Quarter And Full Year Ended December 31, 2023
Baltimore--(business wire)--medifast (nyse: med), the health and wellness company known for its habit-based and coach-guided lifestyle solution, optavia®, will announce financial results for the fourth quarter and full year ended december 31, 2023 on tuesday, february 20, 2024, after market close. the company will host a conference call to discuss the results with additional comments and details. company participants will be dan chard, chairman and chief executive officer, and jim maloney, chie.
Latest News
2024-04-30 13:05:20 - Zacks Investment Research
Medifast (MED) Q1 Earnings Miss Estimates, Revenues Fall Y/Y
Medifast's (MED) first-quarter results reflect challenges related to a decline in active earning OPTAVIA Coaches, lower coach productivity and soft sales volume.
2024-04-30 08:19:19 - InvestorPlace
Why Is Medifast (MED) Stock Down 20% Today?
Medifast (NYSE: MED ) stock is falling on Tuesday after the weight loss company released its earnings report for the first quarter of 2024. The bad news for MED stock comes from its adjusted earnings per share of 66 cents.
2024-04-21 11:33:51 - Seeking Alpha
65 Graham Value Stocks: 54 Fit To Buy For April
Large Cap Value is a value ranking for large cap stocks that looks at the price of a stock relative to measurements of intrinsic firm value. The Ben Graham Formula strategy selects ultra-stable stocks based on criteria such as sales, earnings, and dividend payments. 54 out of 65 All-Star-Value Dividend stocks offer annual dividends that exceed their price per share.
2024-04-16 13:56:06 - Zacks Investment Research
Medifast's (MED) Transformation on Track Amid Macro Headwinds
Medifast (MED) adapts to shifting consumer behavior to maintain its relevance. However, it is facing difficulties in attracting customers due to the rapidly changing economy and inflation.
2024-04-15 16:05:00 - Business Wire
Medifast to Announce Financial Results for the First Quarter Ended March 31, 2024
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the first quarter ended March 31, 2024 on Monday, April 29, 2024, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer. T.
2024-03-18 07:38:09 - Seeking Alpha
68 Graham Value Stocks, 57 Fit To Buy In March
Large Cap Value ranking from YCharts identifies stocks with low prices relative to their assets and profits. Ben Graham Formula strategy selects stable stocks with strong earnings and dividends based on Graham's book "The Intelligent Investor". 57 out of 68 All-Star-Value Dividend stocks offer annual dividends exceeding their price per share.
2024-03-18 06:16:03 - Zacks Investment Research
Medifast (MED) Soars 5.9%: Is Further Upside Left in the Stock?
Medifast (MED) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
2024-03-15 06:57:06 - Seeking Alpha
FSTA: Consumer Staples Sector Dashboard For March
2024-03-13 12:46:10 - Zacks Investment Research
Innovations Aid Medifast (MED), Lower Customer Attraction Ails
Medifast (MED) is foraying into medically supported weight management and sports nutrition segments. However, it continues to encounter difficulties in attracting customers.
2024-03-07 15:58:18 - InvestorPlace
Hey, Bottom Fishers! 3 Beaten Up Stocks to Buy for Short-Term Gains
One tool that bargain hunters can utilize to identify beaten up stocks to buy after significant declines is the relative strength index ( RSI ). The RSI signals when a stock's downward momentum may be exhausted, indicating that a correction could provide upside potential.